Phân tích quang phổ và điện hóa của các phức hợp vàng(I) và vàng(III) với glyoxaldehyde bis(thiosemicarbazones): độc tính tế bào đối với dòng tế bào khối u người và ức chế hoạt động thioredoxin reductase

Afanasieva VA, Glinskaya LA, Klevtsova RF, Mironov IV, Sheludyakova LA (2005) Synthesis and crystal and molecular structure of β-chlorinated acyclic complex of gold(III) [Au(C9H18N4Cl)](ClO4)2. J Struct Chem 46:869–875 Beraldo H, Gambino D (2004) The wide pharmacological versatility of thiosemicarbazones, semicarbazones and their metal complexes. Mini Rev Med Chem 4:31–39 Beraldo H, Boyd LP, West DX (1998) Copper(II) and nickel(II) complexes of glyoxaldehyde bis{N(3)-substituted thiosemicarbazones}. Trans Met Chem 23:67–71 Bindoli A, Rigobello MP, Scutari G, Gabbiani C, Casini A, Messori L (2009) Thioredoxin reductase: a target for gold compounds acting as potential anticancer drugs. Coord Chem Rev 253:1692–1707 Borges RHU, Paniago E, Beraldo H (1997) Equilibrium and kinetic studies of iron(II) and iron(III) complexes of some α(N)-heterocyclic thiosemicarbazones. Reduction of the iron(III) complexes of 2-formylpyridine thiosemicarbazone and 2-acetylpyridine thiosemicarbazone by cellular thiol-like reducing agents. J Inorg Biochem 65:267–275 Casas JS, Castaño MV, Cifuentes MC, García-Monteagudo JC, Sánchez A, Sordo J, Abram U (2004) Complexes of dichloro[2-(dimethylaminomethyl)phenyl-C 1, N]gold(III), [Au(damp-C 1, N)Cl2], with formylferrocene thiosemicarbazones: synthesis, structure and cytotoxicity. J Inorg Biochem 98:1009–1016 Casas JS, Castellano EE, Couce MD, Ellena J, Sánchez A, Sordo J, Taboada C (2006) A gold(I) complex with a vitamin K3 derivative: characterization and antitumoral activity. J Inorg Biochem 100:1858–1860 Casini C, Hartinger C, Gabbiani C, Mini C, Dyson PJ, Keppler BK, Messori L (2008) Gold(III) compounds as anticancer agents: relevance of gold–protein interactions for their mechanism of action. J Inorg Biochem 102:564–575 Castiñeiras A, Pedrido R, Pérez-Alonso G (2008) A Convenient mode to stabilize M(I) metal ions by using thiosemicarbazones. Eur J Inorg Chem 2008:5106–5111 Castiñeiras A, Dehnen S, Fuchs A, García-Santos I, Sevillano P (2009) Stabilization of gold(I) and gold(III) complexes by pyridil bis{3-hexamethylene-iminylthiosemicarbazone}: spectroscopic, structural and computational study. Dalton Trans 15:2731–2739 Cox AG, Brown KK, Arner ES, Hampton MB (2008) The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation. Biochem Pharmacol 76:1097–1109 Evans RC, Douglas P, Winscom CJ (2009) Photophysics and electrochemistry of some thione far-red/near-IR triplet emitters. J Fluoresc 19:169–177 Ferraz KSO, Cardoso GMM, Bertollo CM, Souza-Fagundes EM, Speziali N, Zani CL, Mendes IC, Gomes MA, Beraldo H (2011) N(4)-tolyl-2-benzoylpyridine-derived thiosemicarbazones and their palladium(II) and platinum(II) complexes: cytotoxicity against human solid tumor cells. Polyhedron 30:315–321 Gabbiani C, Casini A, Messori L (2007) Gold(III) compounds as anticancer drugs. Gold Bull 40:73–81 Geary WJ (1971) The use of conductivity measurements in organic solvents for the characterization of coordination compounds. Coord Chem Rev 7:81–122 Khanye SD, Báthori NB, Smith GS, Chibale K (2010) Gold(I) derived thiosemicarbazone complexes with rare halogen–halogen interaction-reduction of [Au(damp-C 1,N)Cl2]. Dalton Trans 39:2697–2700 Kouroulis KN, Hadjikakou SK, Kourkoumelis N, Kubicki M, Male L, Hursthouse M, Skoulika S, Metsios AK, Tyurin VY, Dolganov AV, Milaevag ER, Hadjiliadis N (2009) Synthesis, structural characterization and in vitro cytotoxicity of new Au(III) and Au(I) complexes with thioamides. Dalton Trans 47:10446–10456 Lessa JA, Mendes IC, da Silva PRO, Soares MA, dos Santos RG, Speziali NL, Romeiro NC, Barreiro EJ, Beraldo H (2010) 2-Acetylpyridine thiosemicarbazones: cytotoxic activity in nanomolar doses against malignant gliomas. Eur J Med Chem 45:5671–5677 Lessa JA, Guerra JC, de Miranda LF, Romeiro CFD, Da Silva JG, Mendes IC, Speziali NL, Souza-Fagundes EM, Beraldo H (2011a) Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity. J Inorg Biochem 105:1729–1739 Lessa JA, Reis DC, Mendes IC, Speziali NL, Rocha LF, Pereira VRA, Melo CML, Beraldo H (2011b) Antimony(III) complexes with pyridine-derived thiosemicarbazones: structural studies and investigation on the antitrypanosomal activity. Polyhedron 30:372–380 Lobana TS, Khanna S, Butcher RJ (2008) Synthesis of a fluorescent gold(I) complex with a thiosemicarbazone, [Au2(3-NO2-Hbtsc)4]Cl2·2CH3CN. Inorg Chem Commun 11:1433–1435 Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63 Ott I, Qian X, Xu Y, Vlecken DHW, Marques IJ, Kubutat D, Will J, Sheldrick WS, Jesse P, Prokop A, Bagowski CP (2009) A gold(I) phosphine complex containing a naphthalimide ligand functions as a TrxR inhibiting anti-proliferative agent and angiogenesis inhibitor. J Med Chem 52:763–770 Refaey SAM, Hassan AA, Shehata HS (2008) Electrochemical behavior of some substituted thiosemicarbazones and their reaction products with tetracyanoethylene. Int J Electrochem Sci 3:325–337 Reis DC, Pinto MCX, Souza-Fagundes EM, Wardell SMSV, Wardell JL, Beraldo H (2010) Antimony(III) complexes with 2-benzoylpyridine-derived thiosemicarbazones: cytotoxicity against human leukemia cell lines. Eur J Med Chem 45:3904–3910 Rigobello MP, Messori L, Marcon G, Cinellu MA, Bragadin M, Folda A, Scutari G, Bindoli A (2004) Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions. J Inorg Biochem 98:1634–1641 Santos IG, Hagenbach A, Abram U (2004) Stable gold(III) complexes with thiosemicarbazone derivatives. Dalton Trans 4:677–682 Tiekink ERT (2002) Gold derivatives for the treatment of cancer. Crit Rev Oncol Hematol 42:225–248 Tiekink ERT (2008) Anti-cancer potential of gold complexes. Inflammopharmacology 16:138–142 Ulukaya E, Colakogullari M, Wood EJ (2004) Interference by anti-cancer chemotherapeutic agents in the MTT-tumor chemosensitivity assay. Exp Chem 50:43–50 West DX, Ives JS, Bain GA, Liberta AE, Valdés-Martínez J, Ebert HK, Hernández-Ortega S (1997) Copper(II) and nickel(II) complexes of 2,3-butanedione bis(N(3)-substituted thiosemicarbazones). Polyhedron 16:1895–1905 Zhang T, Wang J, Tai Z, Zhu S (1995) Study on the electrochemical reduction of benzimidazole-2-thione and its 1-1auroyl derivative in organic solvent. J Electroanal Chem 393:55–59